Jpmorgan Chase & CO Acorda Therapeutics Inc Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.52 - $0.77 $0 - $0
1 Added 10.0%
11 $0
Q3 2022

Nov 14, 2022
SELL
$0.29 - $0.53 $0 - $0
-1 Reduced 9.09%
10 $0
Q2 2022

Aug 11, 2022
BUY
$0.3 - $1.67 $0 - $5
3 Added 37.5%
11 $0
Q3 2021

Nov 12, 2021
BUY
$3.36 - $4.79 $26 - $38
8 New
8 $0

Others Institutions Holding ACOR

# of Institutions
1
Shares Held
133K
Call Options Held
0
Put Options Held
0
View Full List

About ACORDA THERAPEUTICS INC

ACOR Quotes by TradingView
  • Ticker ACOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 24,338,400
  • Market Cap $6.33M
  • Description
  • Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...
More about ACOR
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email